Skip to main content
Publications
Mareque M, Montesinos P, Font P, Guinea JM, De La Fuente A, Soto J, Oyaguez I, Brockbank J, Iglesias T, Llinares J, Sierra J. Cost-effectiveness analysis of gemtuzumab ozogamicin for first-line treatment of patients with Cd-33 positive acute myeloid leukaemia in Spain. Clinicoecon Outcomes Res. 2021 Apr 22;2021(13):263-77. doi: 10.2147/CEOR.S302097
Carrasquilla G, Porras A, Martinez S, DeAntonio R, Devadiga R, Talarico C, Caceres D, Juliao P. Pneumococcal disease mortality in children<5 years of age after pneumococcal conjugate vaccine introduction in Colombia: a time-trend analysis, 2005-2016. Poster presented at the 18th International Congress on Infectious Diseases (ICID); March 1, 2018. Buenos Aires, Argentina. [abstract] International journal of infectious diseases and therapy. 2018 Aug; 73(Supplement). doi: 10.1016/j.ijid.2018.04.3922
Yudkin JS, Juhan-Vague I, Hawe E, Humphries SE, Di Minno G, Margaglione M, Tremoli E, Kooistra T, Morange PE, Lundman P, Mohamed-Ali V, Hamsten A, HIFMECH Study Group. HIFMECH Study Group. Low-grade inflammation may play a role in the etiology of the metabolic syndrome in patients with coronary heart disease: the HIFMECH study. Metabolism. 2004 Jul;53(7):852-7.